Dementia Prevention Digest

Gait monitoring could flag Alzheimer's risk years before symptoms via simple, non-invasive checks like walking speed and variability. A Texas A&M team...

Emory researchers found 54 adults with mild cognitive impairment and sleep disturbance who took 5,000+ IU vitamin D scored over 13% higher on the...

The FDA's August 24, 2026 clearance of Roche's Elecsys pTau217 blood test enables simple, minimally invasive amyloid assessment in primary care for...

A newly identified gut metabolite called imidazole propionate (ImP) links microbiome activity directly to Alzheimer’s brain changes.

• Microbiome...

A single-biomarker pTau217 test cleared by the FDA now lets clinicians rule in or rule out amyloid pathology in adults 55+ with cognitive symptoms.

-...

The FDA has cleared C2N's PrecivityAD2 blood test for symptomatic adults as young as 40, the first such approval for this age group. By detecting...

Multisensory virtual tourism emerges as a promising non-pharmacological approach for mild cognitive impairment, the transitional stage between normal aging and early dementia.

• Adults with mild cognitive impairment and sleep issues who took at least 5,000 IU of vitamin D daily scored over 13% higher on the MoCA test.
• The...

The FDA has cleared PrecivityAD2, a blood test developed by C2N Diagnostics using WashU technology and high-resolution mass spectrometry, to aid...

A new study shows controlling blood pressure, avoiding diabetes, and not smoking between ages 45-65 adds nearly 13 dementia-free years.

WHO...

Brief integrated digit-in-noise (iDIN) testing supports paired hearing and cognitive screening in older adults, using a measure commonly applied in dementia diagnosis.

A new self-report tool targets spatial navigation difficulties as an early Alzheimer's signal, often before memory loss appears.

• SPAM...

The FDA cleared PrecivityAD2 as the first blood test for symptomatic adults as young as 40, marking a regulatory milestone for accessible early...

Better multidimensional sleep health strongly predicts lower odds of mild cognitive impairment among older adults.

• Each one-point rise in the...

A novel autologous stem cell therapy, VesCell (ACP-01), is advancing in a Bahamas LARTA trial for vascular cognitive impairment and dementia.

-...

FDA clearance of PrecivityAD2 gives patients an accessible blood-based option to identify amyloid pathology and guide next steps in care.

• The...

• AI brain age from MRI scans flags dementia risk years early by detecting subtle atrophy missed by standard visual ratings
• Each year a brain...

Emory researchers found that 5,000 IU or more of vitamin D daily was linked to better cognitive scores in adults with sleep disturbance and mild...

Alzheimer’s Association funding has produced a simple blood test measuring amyloid plaques, now available through primary care physicians with...

A clear trend is emerging: Alzheimer's brain changes are detectable far sooner than previously assumed, thanks to advanced MRI and AI.

• Structural...